Insider Trading March 17, 2026

ADM Senior Vice President Sells $2.57 Million in Company Stock; Firm Posts Mixed Q4 Results

Christopher M. Cuddy disposes of 35,000 shares as Archer-Daniels-Midland reports an EPS beat but misses on revenue and updates board and price target

By Ajmal Hussain ADM
ADM Senior Vice President Sells $2.57 Million in Company Stock; Firm Posts Mixed Q4 Results
ADM

Archer-Daniels-Midland Co. (ADM) Senior Vice President Christopher M. Cuddy sold 35,000 shares on March 13, 2026, generating $2.57 million at $73.5 per share. The transaction happened near the stock's 52-week high, while ADM recently reported a mixed fourth-quarter 2025 with adjusted EPS above expectations but revenue below forecasts. Corporate governance and analyst updates accompanied the disclosure.

Key Points

  • Christopher M. Cuddy sold 35,000 ADM shares on March 13, 2026, at $73.5 per share, totaling $2.57 million.
  • ADM reported Q4 2025 adjusted EPS of $0.87, above the $0.80 estimate, but revenue of $18.56 billion missed the $21.03 billion forecast - impacting the agricultural and nutrition-related segments.
  • BMO Capital raised its price target to $63.00 from $57.00 while keeping a Market Perform rating; Michael McMurray joined ADM's board and will serve on Audit and Sustainability and Technology committees.

Archer-Daniels-Midland Co. (NASDAQ:ADM) disclosed a notable insider sale this month when Senior Vice President Christopher M. Cuddy sold 35,000 shares of common stock on March 13, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The shares were disposed of at $73.5 each, yielding proceeds of $2.57 million.

The sale took place close to the stock's 52-week high of $73.72; at the time of the filing ADM shares were trading at $72.12. Following the March 13 transaction, Cuddy's direct holdings in Archer-Daniels-Midland total 331,052.0287 shares of common stock. The filing also reports that Cuddy indirectly holds 2,518.15 shares through an employee benefit plan.

The Form 4 notes additional employee-plan activity: between February 13, 2026, and March 13, 2026, Cuddy acquired 18.913 shares of ADM common stock pursuant to an employee benefit plan. The report was signed on Cuddy's behalf by Dana Ng, Attorney-in-Fact, on March 16, 2026.


The insider transaction arrives as ADM's share price has climbed 52.6% over the past year. Analysis cited in the filing indicates the stock appears slightly overvalued relative to its Fair Value, and the company is covered by a comprehensive Pro Research Report available for deeper investor review.

Separately, Archer-Daniels-Midland reported fourth-quarter 2025 financial results that combined an earnings beat with a revenue shortfall. Adjusted earnings per share were $0.87, surpassing the analyst estimate of $0.80. Revenue, however, came in at $18.56 billion, below the expected $21.03 billion.

Management-level performance was mixed by segment: the AS&O segment produced stronger results, while the Nutrition division did not meet expectations. These segment-level outcomes contributed to the overall gap between actual and forecasted revenue.

On the analyst front, BMO Capital adjusted its outlook for ADM by raising the price target to $63.00 from $57.00 while maintaining a Market Perform rating. In corporate governance news, ADM added Michael McMurray, the former CFO of LyondellBasell, to its board of directors. McMurray will serve on the Audit and Sustainability and Technology committees.

Taken together, the insider sale, mixed quarterly results, analyst update, and board appointment provide investors with multiple data points about ADM's near-term financial performance and governance makeup.

Risks

  • Revenue for Q4 2025 fell short of analyst expectations, indicating potential near-term topline pressure in ADM's agricultural and nutrition businesses.
  • The Nutrition division did not meet expectations, representing an operational risk within a key business segment.
  • The stock is described as slightly overvalued relative to its Fair Value, suggesting valuation risk for equity investors.

More from Insider Trading

Astera Labs Director Disposes $325,000 in Stock as Company Posts Strong Q4 Results Mar 17, 2026 GeneDx CEO Sells $1.32M in WGS Stock to Meet RSU Tax Withholding Mar 17, 2026 PACS Group COO Sells $1.24M in Shares as Stock Trades Well Above Analyst Targets Mar 17, 2026 GeneDx CFO Disposes $438K in Stock Following Zero-Strike Option Exercise Mar 17, 2026 Clearwater Analytics CFO Disposes $436K in Shares After Option Exercise Mar 17, 2026